NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types

被引:17
|
作者
D'Agaro, Tiziana [1 ]
Bittolo, Tamara [1 ]
Bravin, Vanessa [1 ]
Dal Bo, Michele [1 ]
Pozzo, Federico [1 ]
Bulian, Pietro [1 ]
Rossi, Francesca M. [1 ]
Zucchetto, Antonella [1 ]
Degan, Massimo [1 ]
D'Arena, Giovanni [2 ]
Chiarenza, Annalisa [3 ]
Zaja, Francesco [4 ]
Pozzato, Gabriele [5 ]
Di Raimondo, Francesco [3 ]
Rossi, Davide [6 ,7 ]
Gaidano, Gianluca [8 ]
Del Poeta, Giovanni [9 ,10 ]
Gattei, Valter [1 ]
Bomben, Riccardo [1 ]
机构
[1] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohaematol Unit, Aviano, PN, Italy
[2] IRCCS, Ctr Riferimento Oncol Basilicata, Oncohaematol Dept, Rionero In Vulture, Italy
[3] Ferrarotto Hosp, Div Haematol, Catania, Italy
[4] Azienda Osped Univ S Maria Misericordia, Ctr Trapianti & Terapie Cellulari Carlo Melzi DIS, Clin Ematol, Udine, Italy
[5] Univ Trieste, Maggiore Gen Hosp, Dept Internal Med & Haematol, Trieste, Italy
[6] Inst Oncol Res, Haematol, Bellinzona, Switzerland
[7] Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[8] Univ Piemonte Orientale, Dept Translat Med, Div Haematol, Novara, Italy
[9] S Eugenio Hosp, Div Haematol, Rome, Italy
[10] Univ Tor Vergata, Rome, Italy
关键词
chronic lymphocytic leukaemia; NOTCH1; mutations; progression-free survival; overall survival; RECURRENT MUTATIONS; SURVIVAL;
D O I
10.1111/bjh.14843
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:597 / 602
页数:6
相关论文
共 50 条
  • [31] NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES
    Baldoni, S.
    Del Papa, B.
    Dorillo, E.
    De Falco, F.
    Rompietti, C.
    Adamo, F. M.
    Cecchini, D.
    Mondani, E.
    Zei, T.
    Fabi, B.
    Cantelmi, M. G.
    Guarente, V.
    Di Ianni, M.
    Rosati, E.
    Sportoletti, P.
    HAEMATOLOGICA, 2020, 105 : S30 - S30
  • [32] Potential impact of NOTCH1 activation on venetoclax sensitivity in chronic lymphocytic Leukaemia: In vitro insights and clinical implications
    Gao, Ming-Yuan
    Georgiou, Angela
    Lin, Victor S.
    Jahja, Michelle
    White, Christine A.
    Anderson, Mary Ann
    Mccormack, Matthew P.
    Roberts, Andrew W.
    Huang, David C. S.
    Thijssen, Rachel
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1389 - 1394
  • [33] Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
    F Nadeu
    G Clot
    J Delgado
    D Martín-García
    T Baumann
    I Salaverria
    S Beà
    M Pinyol
    P Jares
    A Navarro
    H Suárez-Cisneros
    M Aymerich
    M Rozman
    N Villamor
    D Colomer
    M González
    M Alcoceba
    M J Terol
    B Navarro
    E Colado
    ÁR Payer
    X S Puente
    C López-Otín
    A López-Guillermo
    A Enjuanes
    E Campo
    Leukemia, 2018, 32 : 645 - 653
  • [34] CLINICAL IMPACT OF THE SUBCLONAL ARCHITECTURE AND MUTATIONAL COMPLEXITY IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Nadeu, F.
    Clot, G.
    Delgado, J.
    Martin-Garcia, D.
    Baumann, T.
    Salaverria, I.
    Bea, S.
    Pinyol, M.
    Jares, P.
    Navarro, A.
    Suarez-Cisneros, H.
    Aymerich, M.
    Rozman, M.
    Villamor, N.
    Colomer, D.
    Gonzalez, M.
    Alcoceba, M.
    Terol, M. J.
    Navarro, B.
    Colado, E.
    Puente, X. S.
    Lopez-Otin, C.
    Lopez-Guillermo, A.
    Enjuanes, A.
    Campo, E.
    HAEMATOLOGICA, 2017, 102 : 9 - 9
  • [35] Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
    Nadeu, F.
    Clot, G.
    Delgado, J.
    Martin-Garcia, D.
    Baumann, T.
    Salaverria, I.
    Bea, S.
    Pinyol, M.
    Jares, P.
    Navarro, A.
    Suarez-Cisneros, H.
    Aymerich, M.
    Rozman, M.
    Villamor, N.
    Colomer, D.
    Gonzalez, M.
    Alcoceba, M.
    Terol, M. J.
    Navarro, B.
    Colado, E.
    Payer, A. R.
    Puente, X. S.
    Lopez-Otin, C.
    Lopez-Guillermo, A.
    Enjuanes, A.
    Campo, E.
    LEUKEMIA, 2018, 32 (03) : 645 - 653
  • [36] NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia
    McGovern, Brianan
    Quinn, Fiona
    Andrews, Clare
    Jeffers, Michael
    Bacon, Christopher L.
    Bird, Brian
    Crotty, Gerard
    Vandenberghe, Elisabeth
    Flavin, Richard
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 732 - 735
  • [37] Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
    Nadeu, Ferran
    Delgado, Julio
    Royo, Cristina
    Baumann, Tycho
    Stankovic, Tatjana
    Pinyol, Magda
    Jares, Pedro
    Navarro, Alba
    Martin-Garcia, David
    Bea, Silvia
    Salaverria, Itziar
    Oldreive, Ceri
    Aymerich, Marta
    Suarez-Cisneros, Helena
    Rozman, Maria
    Villamor, Neus
    Colomer, Dolors
    Lopez-Guillermo, Armando
    Gonzalez, Marcos
    Alcoceba, Miguel
    Jose Terol, Maria
    Colado, Enrique
    Puente, Xose S.
    Lopez-Otin, Carlos
    Enjuanes, Anna
    Campo, Elias
    BLOOD, 2016, 127 (17) : 2122 - 2130
  • [38] Outcomes in Chronic Lymphocytic Leukemia Patients With NOTCH1 Signaling Pathway Mutations
    O'Brien, Susan M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (07) : 23 - 24
  • [39] A novel NOTCH1 PEST domain mutation in a case of chronic lymphocytic leukemia
    Sportoletti, Paolo
    Baldoni, Stefano
    Del Papa, Beatrice
    Cantaffa, Renato
    Ciurnelli, Raffaella
    Aureli, Patrizia
    Rosati, Emanuela
    Marconi, Pierfrancesco
    Di Ianni, Mauro
    Falzetti, Franca
    LEUKEMIA & LYMPHOMA, 2013, 54 (08) : 1780 - 1782
  • [40] NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
    Rosati, Emanuela
    Baldoni, Stefano
    De Falco, Filomena
    Del Papa, Beatrice
    Dorillo, Erica
    Rompietti, Chiara
    Albi, Elisa
    Falzetti, Franca
    Di Ianni, Mauro
    Sportoletti, Paolo
    FRONTIERS IN ONCOLOGY, 2018, 8